Dapagliflozin Improves Left Ventricular Myocardial Longitudinal Function in Patients With Type 2 Diabetes
Alexander Brown, Stephen Gandy, Ify Mordi, Rory J. McCrimmon, Prasad Guntur Ramkumar, J. Graeme Houston, Allan D. Struthers, Chim C. Lang
Topics & Concepts
DapagliflozinSubclinical infectionMedicineInternal medicineCardiologyDiabetes mellitusHeart failureType 2 diabetesType 2 Diabetes MellitusVentricular functionEndocrinologyDiabetes Treatment and ManagementMetabolism, Diabetes, and CancerPancreatic function and diabetes